Back

Outcomes of sodium-glucose co-transporter type 2 inhibitors use in elderly patients with heart failure with reduced ejection fraction

28 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Cardiovascular disease in the elderly 2 Cardiovascular Disease in the Elderly ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Jorge Balaguer

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Impact of dementia and drug compliance on patients with acute myocardial infarction
Associate Professor W. Lee (Seongnam, KR)
Abstract Slides
Presentation thumbnail
Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe
Doctor T. de Vries (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Pattern of cardiovascular risk factors and outcomes of patients older than 80 years and presenting with acute coronary syndromes
Doctor A. El Amrawy (Alexandria, EG)
Abstract Slides
Presentation thumbnail
Phenotyping patient-reported health profiles in octogenarians with coronary artery disease - a latent profile analysis
Miss I. Instenes (Bergen, NO)
Abstract Slides
Presentation thumbnail
Impact of transfer status on coronary artery bypass graft surgery outcomes
Doctor A. Gill (Las Vegas, US)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular disease in the elderly 2

The Event

Event poster

ESC Congress 2022

28 August 2022 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources